ArticleNeuropsychiatric disease and treatment2018

Safety and effectiveness of rapid-acting intra-muscular olanzapine for agitation associated with schizophrenia - Japan postmarketing surveillance study.

Hideaki Katagiri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.